| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | Director | Stock Option (right to buy) | 36K | Jun 26, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | Jun 26, 2025 | 1 | $0 | 4 | Jun 30, 2025 | Director |
| FULC | Fulcrum Therapeutics, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
| FULC | Fulcrum Therapeutics, Inc. | Jun 27, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
| FULC | Fulcrum Therapeutics, Inc. | Jun 27, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
| FULC | Fulcrum Therapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 9, 2021 | Director |
| FULC | Fulcrum Therapeutics, Inc. | Dec 8, 2021 | 0 | $0 | 3 | Dec 9, 2021 | Director |